SK Capital to Buy Apotex Pharmaceutical

Funding Rounds

▤ Summary

The amount of the deal – closing of which is subject to the satisfaction of customary regulatory conditions – was not disclosed. RBC Capital Markets, The Bank of Nova Scotia, HSBC and Truist Securities are providing committed financing in support of the transaction. With the acquisition, SK Capital will be supporting Apotex’s next phase of growth and continued innovation. Led by CEO Jeff Watson, Apotex is a pharmaceutical company that produces medicines for patients around the world. Its employs nearly 8,000 people worldwide in manufacturing, R&D, and commercial operations.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors SK하이닉스 Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies